Apoptotic Marker Analysis in Heated-Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases.

Eran Nizri; Yuval Dranizky; Kelly Lipczyc; R. Uzana; Almog Ben-Yaakov; Aviram Nissan; G. Lahat; Yaniv Berger; Ravit Geva

doi:10.1002/jso.70226

March 3, 2026

Apoptotic Marker Analysis in Heated-Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases.

View at Publisher

Ask AI

Bookmark

Share

Key Points

To evaluate the correlation between apoptotic markers in HIPEC effluent and the risk of recurrence in patients with peritoneal metastases.
Pilot study design
Analysis of apoptotic markers in HIPEC effluent fluid
Histology-agnostic approach
Apoptotic markers correlate with recurrence risk
Potential to improve patient selection for adjuvant therapies

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Pilot study analyzes biomarkers in HIPEC fluid, indicating recurrence risk in patients with peritoneal metastases.

Abstract

In this pilot study, apoptotic markers in HIPEC effluent are a histology-agnostic assay that correlates with recurrence risk. This biomarker may improve patient selection for adjuvant therapies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nizri et al. (2026) studied this question.

synapsesocial.com/papers/69aa7037531e4c4a9ff59cf9 https://doi.org/10.1002/jso.70226

View at Publisher

Ask AI

Bookmark

Share

Apoptotic Marker Analysis in Heated-Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Apoptotic Marker Analysis in Heated-Intraperitoneal Chemotherapy Effluent Fluid Is Associated With Prognosis in Patients With Peritoneal Metastases.

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading